Header Logo

Connection

Naoko Takebe to Salivary Gland Neoplasms

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Salivary Gland Neoplasms.
Naoko Takebe
Connection Strength
0.127
Salivary Gland Neoplasms
  1. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Ann Oncol. 2016 Feb; 27(2):318-23.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.